Birth Defects

Reproductive and Perinatal Epidemiology

Volumn , Issue , 2011, Pages

  Werler, Martha M ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

Case control studies; Congenital anomalies; Methods; Organogenesis; Risk factors; Teratogens

Indexed keywords

EID: 84921259090     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780195387902.003.0049     Document Type: Chapter

References (70)

1. Alwan, S., Reefhuis, J., Rasmussen, S.A., Olney, R.S., and Friedman, J.M. 2007. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 356)(26): 2684-92.
2. Amorim, M.R., Lima, M.A., Castilla, E.E., and Orioli, I.M. 2007. Non-Latin European descent could be a requirement for association of NTDs and MTHFR variant 677C 〈 T: A meta-analysis. Am J Med Genet A 143A(15): 1726-32.
3. Ananth, C.V., Platt, R.W., and Savitz, D.A. 2005. Regression models for clustered binary responses: Implications of ignoring the intracluster correlation in an analysis of perinatal mortality in twin gestations. Ann Epidemiol 15)(4): 293-301.
4. Barton, T.S., Robaire, B., and Hales, B.F. 2005. Epigenetic programming in the preimplantation rat embryo is disrupted by chronic paternal cyclophosphamide exposure. Proc Natl Acad Sci USA 102)(22): 7865-70.
5. Berard, A., Ramos, E., Rey, E., Blais, L., St-Andre, M., and Oraichi, D. 2007. First trimester exposure to paroxetine and risk of cardiac malformations in infants: The importance of dosage. Birth Defects Res B Dev Reprod Toxicol 80)(1): 18-27.
6. Buka, S.L., Goldstein, J.M., Spartos, E., and Tsuang, M.T. 2004. The retrospective measurement of prenatal and perinatal events: Accuracy of maternal recall. Schizophr Res 71)(2-3): 417-26.
7. Cordier, S. 2008. Evidence for a role of paternal exposures in developmental toxicity. Basic Clin Pharmacol Toxicol 102)(2): 176-81.
8. Cragan, J.D., Martin, M.L., Moore, C.A., and Khoury, M.J. 1993. Descriptive epidemiology of small intestinal atresia, Atlanta, Georgia. Teratology 48)(5): 441-50.
9. Davis, D.L., Friedler, G., Mattison, D., and Morris, R. 1992. Male-mediated teratogenesis and other reproductive effects: Biologic and epidemiologic findings and a plea for clinical research. Reprod Toxicol 6)(4): 289-92.
10. Diav-Citrin, O., Shechtman, S., Weinbaum, D., Wajnberg, R., Avgil, M., Di Gianantonio, E., et al. 2008. Paroxetine and fluoxetine in pregnancy: A prospective, multicentre, controlled, observational study. Br J Clin Pharmacol 66)(5): 695-705.
11. Drews, C.D., Kraus, J.F., and Greenland, S. 1990. Recall bias in a case-control study of sudden infant death syndrome. Int J Epidemiol 19)(2): 405-11.
12. Dunn, P.M. 2007. Perinatal lessons from the past: Sir Norman Gregg, ChM, MC, of Sydney (1892-1966) and rubella embryopathy. Arch Dis Child Fetal Neonatal Ed 92(6): F513-14.
13. Felix, R.J., Jones, K.L., Johnson, K.A., McCloskey, C.A., and Chambers, C.D. 2004. Postmarketing surveillance for drug safety in pregnancy: The Organization of Teratology Information Services project. Birth Defects Res A Clin Mol Teratol 70)(12): 944-47.
14. Ferenz, C., Loffredo, C., Correa-Villasenor, A., and Wilson, P. 1997. Genetic and environmental risk factors of major cardiovascular malformations: The Baltimore-Washington Infant Study 1981-1989. In Perspectives in pediatric cardiology, Vol. 5, R. Anderson, ed. Armonk, NY: Future Publishing Co, Inc.
15. Glinianaia, S.V., Rankin, J., and Wright, C. 2008. Congenital anomalies in twins: A registerbased study. Hum Reprod 23)(6): 1306-11.
16. Hansen, M., Kurinczuk, J.J., Bower, C., and Webb, S. 2002. The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. N Engl J Med 346)(10): 725-30.
17. Heinonen, O., Slone, D., and Sharpiro, S. 1977. Birth defects and drugs in pregnancy. Littleton, MA: Publishing Sciences Group, Inc.
18. Henderson, J., Gray, R., and Brocklehurst, P. 2007. Systematic review of effects of lowmoderate prenatal alcohol exposure on pregnancy outcome. ;BJOG 114)(3): 243-52.
19. Holmes, L.B., Kleiner, B.C., Leppig, K.A., Cann, C.I., Munoz, A., and Polk, B.F. 1987. Predictive value of minor anomalies: II. Use in cohort studies to identify teratogens. Teratology 36)(3): 291-97.
20. Honein, M.A., Rasmussen, S.A., Reefhuis, J., Romitti, P.A., Lammer, E.J., Sun, L., and Correa, A. 2007. Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology 18)(2): 226-33.
21. International Clearinghouse for Birth Defects Monitoring Systems. 1991. Congenital malformations worldwide. Amsterdam: Elsevier.
22. Jacobson, S.W., Jacobson, J.L., Sokol, R.J., Martier, S.S., Ager, J.W., and Kaplan, M.G. 1991. Maternal recall of alcohol, cocaine, and marijuana use during pregnancy. Neurotoxicol Teratol 13)(5): 535-40.
23. Johnson, C.Y. and Little, J. 2008. Folate intake, markers of folate status and oral clefts: Is the evidence converging? Int J Epidemiol 37)(5): 1041-58.
24. Jurek, A.M., Greenland, S., Maldonado, G., and Church, T.R. 2005. Proper interpretation of non-differential misclassification effects: Expectations vs observations. Int J Epidemiol 34)(3): 680-87.
25. Kalter, H. and Warkany, J. 1983. Medical progress. Congenital malformations: Etiologic factors and their role in prevention (first of two parts). N Engl J Med 308)(8): 424-31.
26. Kenneson, A. and Cannon, M.J. 2007. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 17)(4): 253-76.
27. Klemetti, A. and Saxen, L. 1967. Prospective versus retrospective approach in the search for environmental causes of malformations. Am J Public Health Nations Health 57)(12): 2071-75.
28. Koren, G., Pastuszak, A., and Ito, S. 1998. Drugs in pregnancy. N Engl J Med 338)(16): 1128-37.
29. Korones, S.B. 1986. Congenital rubella: An encapsulated review. In Teratogen update: Environmentally induced birth defect risks, pp. 77-80. New York: Alan R. Liss, Inc.
30. Krall, E.A., Valadian, I., Dwyer, J.T., and Gardner, J. 1988. Recall of childhood illnesses. J Clin Epidemiol 41)(11): 1059-64.
31. Lam, P.K., Torfs, C.P., and Brand, R.J. 1999. A low pregnancy body mass index is a risk factor for an offspring with gastroschisis. Epidemiology 10)(6): 717-21.
32. Lammer, E.J., Shaw, G.M., Iovannisci, D.M., and Finnell, R.H. 2005. Maternal smoking, genetic variation of glutathione s-transferases, and risk for orofacial clefts. Epidemiology 16)(5): 698-701.
33. Lenz, W. 1962. Thalidomide and congenital abnormalities. Lancet 1: 271-72.
34. Leppig, K.A., Werler, M.M., Cann, C.I., Cook, C.A., and Holmes, L.B. 1987. Predictive value of minor anomalies. I. Association with major malformations. J Pediatr 110)(4): 531-37.
35. Lewis, J.D., Strom, B.L., Kimmel, S.E., Farrar, J., Metz, D.C., Brensinger, C., et al. 2006. Predictors of recall of over-the-counter and prescription non-steroidal anti-inflammatory drug exposure. Pharmacoepidemiol Drug Saf 15)(1): 39-45.
36. Louik, C., Lin, A.E., Werler, M.M., Hernandez-Diaz, S., and Mitchell, A.A. 2007. Firsttrimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 356)(26): 2675-83.
37. Mackenzie, S.G. and Lippman, A. 1989. An investigation of report bias in a case-control study of pregnancy outcome. Am J Epidemiol 129)(1): 65-75.
38. Martinez-Frias, M.L. 2007. Postmarketing analysis of medicines: Methodology and value of the spanish case-control study and surveillance system in preventing birth defects. Drug Saf 30)(4): 307-16.
39. MMWR. 1998. Trends in infant mortality attributable to birth defects: United States, 1980-1995. MMWR Morb Mortal Wkly Rep 47)(37): 773-78.
40. MRC. 1991. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 338)(8760): 131-37.
41. Mulinare, J., Cordero, J.F., Erickson, J.D., and Berry, R.J. 1988. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 260(21): 3141-45.
42. Must, A., Phillips, S.M., Naumova, E.N., Blum, M., Harris, S., Dawson-Hughes, B., and Rand, W.M. 2002. Recall of early menstrual history and menarcheal body size: After 30 years, how well do women remember? Am J Epidemiol 155)(7): 672-79.
43. NBDPN. 2007. State birth defects surveillance program directory. Birth Defects Res A Clin Mol Teratol 79)(12): 815-73.
44. Paganini-Hill, A. and Ross, R.K. 1982. Reliability of recall of drug usage and other healthrelated information. Am J Epidemiol 116)(1): 114-22.
45. Passos-Bueno, M.R., Serti Eacute, A.E., Jehee, F.S., Fanganiello, R., and Yeh, E. 2008. Genetics of craniosynostosis: genes, syndromes, mutations and genotype-phenotype correlations. Front Oral Biol 12: 107-43.
46. Peller, A.J., Westgate, M.N., and Holmes, L.B. 2004. Trends in congenital malformations, 1974-1999: Effect of prenatal diagnosis and elective termination. Obstet Gynecol 104(5 Pt 1): 957-64.
47. Petrini, J., Damus, K., and Johnston, R.B. 1998. Trends in infant mortality attributable to birth defects: United States, 1980-1995. MMWR Morb Mortal Wkly Rep 47)(37): 773-78.
48. Rasmussen, S.A. and Moore, C.A. 2001. Effective coding in birth defects surveillance. Teratology 64(Suppl 1): S3-S7.
49. Reefhuis, J. and Honein, M.A. 2004. Maternal age and non-chromosomal birth defects, Atlanta, 1968-2000: Teenager or thirty-something, who is at risk? Birth Defects Res A Clin Mol Teratol 70)(9): 572-79.
50. Reefhuis, J., Honein, M.A., Schieve, L.A., Correa, A., Hobbs, C.A., and Rasmussen, S.A. 2009. Assisted reproductive technology and major structural birth defects in the United States. Hum Reprod 24)(2): 360-66.
51. Rothman, K.J., Fyler, D.C., Goldblatt, A., and Kreidberg, M.B. 1979. Exogenous hormones and other drug exposures of children with congenital heart disease. Am J Epidemiol 109)(4): 433-39.
52. Sanderson, M., Williams, M.A., White, E., Daling, J.R., Holt, V.L., Malone, K.E., et al. 1998. Validity and reliability of subject and mother reporting of perinatal factors. Am J Epidemiol 147)(2): 136-40.
53. Shaw, G.M., Schaffer, D., Velie, E.M., Morland, K., and Harris, J.A. 1995. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 6)(3): 219-26.
54. Shaw, G.M., Quach, T., Nelson, V., Carmichael, S.L., Schaffer, D.M., Selvin, S., and Yang, W. 2003. Neural tube defects associated with maternal periconceptional dietary intake of simple sugars and glycemic index. Am J Clin Nutr 78)(5): 972-78.
55. Tomeo, C.A., Rich-Edwards, J.W., Michels, K.B., Berkey, C.S., Hunter, D.J., Frazier, A.L., et al. 1999. Reproducibility and validity of maternal recall of pregnancy-related events. Epidemiology 10)(6): 774-77.
56. Torfs, C.P., Christianson, R.E., Iovannisci, D.M., Shaw, G.M., and Lammer, E.J. 2006. Selected gene polymorphisms and their interaction with maternal smoking, as risk factors for gastroschisis. Birth Defects Res A Clin Mol Teratol 76)(10): 723-30.
57. Torfs, C.P., Curry, C.J., and Bateson, T.F. 1995. Population-based study of tracheoesophageal fistula and esophageal atresia. Teratology 52)(4): 220-32.
58. Van Beynum, I.M., den Heijer, M., Blom, H.J., and Kapusta, L. 2007. The MTHFR 677C-T polymorphism and the risk of congenital heart defects: A literature review and meta-analysis. ;QJM 100)(12): 743-53.
59. Waitzman, N.J., Romano, P.S., and Scheffler, R.M. 1994. Estimates of the economic costs of birth defects. Inquiry 31)(2): 188-205.
60. Waller, D.K., Mills, J.L., Simpson, J.L., Cunningham, G.C., Conley, M.R., Lassman, M.R., and Rhoads, G.G. 1994. Are obese women at higher risk for producing malformed offspring? Am J Obstet Gynecol 170)(2): 541-48.
61. Waller, D.K., Shaw, G.M., Rasmussen, S.A., Hobbs, C.A., Canfield, M.A., Siega-Riz, A.M., et al. 2007. Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med 161)(8): 745-50.
62. Werler, M.M., Hayes, C., Louik, C., Shapiro, S., and Mitchell, A.A. 1999. Multivitamin supplementation and risk of birth defects. Am J Epidemiol 150)(7): 675-82.
63. Werler, M.M., Louik, C., Shapiro, S., and Mitchell, A.A. 1996. Prepregnant weight in relation to risk of neural tube defects. ;JAMA 275)(14): 1089-92.
64. Werler, M.M., Mitchell, A.A., Moore, C.A., Honein, M.A., and the National Birth Defects Prevention Network. 2009. Is there epidemiologic evidence to support vascular disruption as a pathogenesis of gastroschisis? Am J Med Genet A 149A(7): 1399-406.
65. Werler, M.M., Shapiro, S., and Mitchell, A.A. 1993. Periconceptional folic acid exposure and risk of occurrent neural tube defects. ;JAMA 269)(10): 1257-61.
66. Werler, M.M., Sheehan, J.E., and Mitchell, A.A. 2002. Maternal medication use and risks of gastroschisis and small intestinal atresia. Am J Epidemiol 155)(1): 26-31.
67. Wyszynski, D.F. 2009. Pregnancy exposure registries: Academic opportunities and industry responsibility. Birth Defects Res A Clin Mol Teratol 85)(1): 93-101.
68. Yawn, B.P., Suman, V.J., and Jacobsen, S.J. 1998. Maternal recall of distant pregnancy events. J Clin Epidemiol 51)(5): 399-405.
69. Yazdy, M.M., Liu, S., Mitchell, A.A., and Werler, M.M. 2010. Maternal dietary glycemic intake and the risk of neural tube defects. Am J Epidemiol 171(4):407-14.
70. Zierler, S. and Rothman, K.J. 1985. Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy. N Engl J Med 313)(6): 347-52.